These results demonstrated that blockage of ATF4-SPHK1 signaling attenuated the deleterious molecular event of EMT, confirming the critical role of ATF4-SPHK1 signaling in GBM aggressive growth and GBM TMZ resistance. The gene discussed is SPHK1; the disease is glioblastoma.